The IL2RA gene helps immune cells respond to a signal called interleukin 2, which supports immune balance and the work of regulatory T cells that stop the body from attacking itself. If this gene does not work properly, some people may develop repeated infections, ongoing inflammation, or autoimmune illness. Rare severe variants can cause a clear immune condition, while some more common variants are linked to a small change in the risk of conditions such as type 1 diabetes and multiple sclerosis.
What is a gene?
Genes are sections of DNA that give your cells instructions to make molecules or to manage processes in the body. Some genes hold the information needed to produce proteins, the working parts of cells. Other genes are used mainly to regulate when certain processes happen, where they take place, and how strongly they operate. As a group, genes affect how the body develops and works, and they can shape how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
IL2RAGene function
What if the gene works
The IL2RA gene helps make part of a receptor on immune cells that responds to interleukin-2, an immune signal. This supports T cell growth and the calming function of regulatory T cells.
Risk
What if the gene does not work
When the IL2RA gene does not work properly, immune control can break down. People may have recurrent infections, inflammation, and autoimmune problems, sometimes affecting the bowel or blood cells; milder or more severe variants can change onset and severity.
Treatment
What does that mean for your treatment
For pathogenic variants in the IL2RA gene, no IL2RA-specific treatment or drug selection approach is currently established. Its protein, CD25, remains an active research target and biomarker in transplant medicine, autoimmune disease, and some blood cancers.
Conditions associated with IL2RA
Gene function
What if the gene works
Your immune system uses the IL2RA gene to read one of its key growth signals. It helps certain white blood cells sense interleukin 2, a messenger that supports activation, survival, and balance. This is a core part of how the IL2RA gene helps control immune responses.
The IL2RA gene makes a receptor piece called CD25 that sits on the surface of immune cells. This piece helps the cell catch interleukin 2, especially when paired with other receptor parts.
After a T cell is switched on, CD25 helps it respond more strongly to interleukin 2. This supports controlled cell growth and division during a normal immune response.
Many regulatory T cells, which help keep immune reactions in check, carry high levels of CD25. This helps them use interleukin 2 to maintain balance and support tolerance to the body’s own tissues.
IL2RA joins with two partner proteins to form the high affinity interleukin 2 receptor, meaning a very sensitive version of the receptor. This lets immune cells detect small amounts of the signal and respond at the right time.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the IL2RA gene can reduce how much CD25 protein reaches the surface of immune cells or how well it helps them respond to IL-2, an important immune signal. This helps explain how IL2RA gene variants affect immune signaling: milder variants may leave some signaling in place, while more severe variants can cause little or no working protein. In people with IL2RA-related immune dysregulation, greater loss of function often links to earlier or broader symptoms.
How variants are linked to conditions
Rare disease-causing variants inherited in both copies of the IL2RA gene can cause an immune condition with repeated infections, enlarged lymph nodes, and autoimmune problems such as bowel inflammation or low blood counts. More common variants in the IL2RA gene linked to autoimmune conditions have been associated with type 1 diabetes and multiple sclerosis, and sometimes autoimmune thyroid disease. These common variants can change risk, but they do not mean a person will definitely develop one of these conditions.
A variant is not necessarily a diagnosis
Gene variants are a typical part of human biology and are common throughout the general population. Most do not have a direct impact on health and simply represent natural variation among people. For many genes, carrying a variant connected with a condition suggests a possible association rather than a confirmed diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that clearly increase or reduce risk related to IL2RA itself. Some changes in IL2RA are linked with a tendency toward immune-related conditions, but overall risk also depends on many other genes and non-genetic factors, so anyone concerned about personal risk should speak with a doctor or genetic counselor.
Inheritance of IL2RA variants
For families asking about the inheritance of IL2RA gene variants, the well established pattern is autosomal recessive for IL2RA-related disease. This means a child usually inherits one altered copy of the IL2RA gene from each parent, and parents who carry one altered copy are often unaffected. When both parents are carriers, each pregnancy has a 25% chance of the child having the condition, a 50% chance of the child being a carrier, and a 25% chance of inheriting two typical copies. Because the IL2RA gene is on chromosome 10, this pattern is the same for males and females.
What does my IL2RA result mean for my family?
For IL2RA, family meaning is usually clearest when a child has a condition caused by changes in both copies of the gene. In that situation, parents are often healthy carriers, brothers and sisters may also be affected or may be carriers, and other close relatives could carry the same change. This can help explain why testing is sometimes discussed within families after an IL2RA result is found.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the IL2RA gene, doctors can use IL2RA genetic testing on a blood sample or saliva sample. A lab reads the DNA code to check for variants and compares the result with known patterns, which can help clarify whether a person carries a variant linked to an IL2RA related condition.
When should I consider getting a genetic test?
Testing for the IL2RA gene may be worth considering when someone has an unusual mix of repeated infections and early immune problems where the body attacks its own tissues, especially if close relatives have had similar symptoms. It can help show whether a harmful change in IL2RA is the cause.
A genetic result is only one part of your health story
Genetic findings can be informative, but how much they reveal varies based on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body responds to some medicines. Small differences in genes can affect how a drug is absorbed, broken down, moved through the body, or how strongly it acts on its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else. These differences are common and are only one part of the bigger picture, along with age, overall health, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. It studies gene-drug patterns to help explain why the same treatment can work differently in different people. With many medications, genes influence either how strongly a drug works or how the body handles it. This information can support treatment choices that are more informed and more individualized. More detailed information on this subject is available in the LearnHub.
Drugs influenced by the IL2RA gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted, so questions about side effects, benefits, or treatment changes are best discussed with your doctor. Research on the IL2RA gene has looked at whether it may affect response to some immune-targeting treatments, but this work is not used routinely to guide care.
History
IL2RA entered medical research in the late 1970s and early 1980s, when scientists were trying to understand how immune cells communicate during infection and inflammation. It was first recognized through work on activated T cells and a cell surface marker later called CD25. Researchers also identified it in studies of adult T cell leukemia, where it was known as the Tac antigen, an early clue that this receptor had broad importance in immune biology. From these first observations, research expanded steadily. By the 1990s and 2000s, IL2RA had become part of major work on autoimmune conditions such as type 1 diabetes and multiple sclerosis, helping shape modern immune genetics.